Matthew S. Lalonde

650 total citations
13 papers, 478 citations indexed

About

Matthew S. Lalonde is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Matthew S. Lalonde has authored 13 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Virology, 7 papers in Infectious Diseases and 6 papers in Molecular Biology. Recurrent topics in Matthew S. Lalonde's work include HIV Research and Treatment (10 papers), HIV/AIDS drug development and treatment (6 papers) and HIV/AIDS Research and Interventions (5 papers). Matthew S. Lalonde is often cited by papers focused on HIV Research and Treatment (10 papers), HIV/AIDS drug development and treatment (6 papers) and HIV/AIDS Research and Interventions (5 papers). Matthew S. Lalonde collaborates with scholars based in United States, Uganda and Germany. Matthew S. Lalonde's co-authors include Ayesha Rahman, Salahuddin Ahmed, Absar-ul Hasnain, Tariq M. Haqqi, Victor M. Goldberg, Eric J. Arts, Michael A. Lobritz, Steven L. Alam, Jun Arii and Gaëlle Mercenne and has published in prestigious journals such as PLoS ONE, The Journal of Physical Chemistry B and Cancer Research.

In The Last Decade

Matthew S. Lalonde

13 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew S. Lalonde United States	11	181	154	147	73	69	13	478
Beata Orzechowska Poland	13	110 0.6×	226 1.5×	47 0.3×	16 0.2×	72 1.0×	35	580
Hsinyi Tsang United States	15	170 0.9×	176 1.1×	167 1.1×	23 0.3×	32 0.5×	29	596
John B. Schell United States	9	63 0.3×	115 0.7×	62 0.4×	230 3.2×	32 0.5×	15	580
Ting-Hsu Lin Taiwan	14	22 0.1×	202 1.3×	57 0.4×	29 0.4×	48 0.7×	23	487
Qingduan Wang China	15	39 0.2×	276 1.8×	115 0.8×	22 0.3×	35 0.5×	36	631
T Murayama Japan	12	24 0.1×	126 0.8×	54 0.4×	23 0.3×	43 0.6×	24	578
Francesca Trimboli Italy	13	80 0.4×	219 1.4×	36 0.2×	21 0.3×	23 0.3×	29	596
Jinghua Yu China	16	18 0.1×	374 2.4×	83 0.6×	19 0.3×	40 0.6×	40	686
Denise Fecchio Brazil	17	23 0.1×	161 1.0×	121 0.8×	22 0.3×	70 1.0×	29	547

Countries citing papers authored by Matthew S. Lalonde

Since Specialization

Citations

This map shows the geographic impact of Matthew S. Lalonde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew S. Lalonde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew S. Lalonde more than expected).

Fields of papers citing papers by Matthew S. Lalonde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew S. Lalonde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew S. Lalonde. The network helps show where Matthew S. Lalonde may publish in the future.

Co-authorship network of co-authors of Matthew S. Lalonde

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew S. Lalonde. A scholar is included among the top collaborators of Matthew S. Lalonde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew S. Lalonde. Matthew S. Lalonde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Pathi, Satya S., Yuta Matsumura, Ethika Tyagi, et al.. (2021). Abstract 606: Pkm2 activation modulates the tumor-immune microenvironment and enhances response to checkpoint inhibitors in preclinical solid tumor models. Cancer Research. 81(13_Supplement). 606–606. 2 indexed citations

Lalonde, Matthew S., et al.. (2019). Mechanistic Investigation of HIV-1 Gag Association with Lipid Membranes. The Journal of Physical Chemistry B. 123(22). 4673–4687. 12 indexed citations

Mercenne, Gaëlle, Steven L. Alam, Jun Arii, Matthew S. Lalonde, & Wesley I. Sundquist. (2015). Angiomotin functions in HIV-1 assembly and budding. eLife. 4. 40 indexed citations

Santos, André F., Denis M. Tebit, Matthew S. Lalonde, et al.. (2012). Effect of Natural Polymorphisms in the HIV-1 CRF02_AG Protease on Protease Inhibitor Hypersusceptibility. Antimicrobial Agents and Chemotherapy. 56(5). 2719–2725. 11 indexed citations

Lalonde, Matthew S., Michael A. Lobritz, Annette N. Ratcliff, et al.. (2011). Inhibition of Both HIV-1 Reverse Transcription and Gene Expression by a Cyclic Peptide that Binds the Tat-Transactivating Response Element (TAR) RNA. PLoS Pathogens. 7(5). e1002038–e1002038. 62 indexed citations

Tebit, Denis M., Michael A. Lobritz, Matthew S. Lalonde, et al.. (2010). Divergent Evolution in Reverse Transcriptase (RT) of HIV-1 Group O and M Lineages: Impact on Structure, Fitness, and Sensitivity to Nonnucleoside RT Inhibitors. Journal of Virology. 84(19). 9817–9830. 23 indexed citations

Lalonde, Matthew S. & Eric J. Arts. (2010). DNA Suspension Arrays: Silencing Discrete Artifacts for High-Sensitivity Applications. PLoS ONE. 5(11). e15476–e15476. 4 indexed citations

Santos, André F., Matthew S. Lalonde, Denis M. Tebit, et al.. (2009). Mutation T74S in HIV-1 subtype B and C proteases resensitizes them to ritonavir and indinavir and confers fitness advantage. Journal of Antimicrobial Chemotherapy. 64(5). 938–944. 11 indexed citations

Dudley, Dawn M., et al.. (2009). Selection of a Simian-Human Immunodeficiency Virus Strain Resistant to a Vaginal Microbicide in Macaques. Journal of Virology. 83(10). 5067–5076. 19 indexed citations

10.

Troyer, Ryan M., Matthew S. Lalonde, Korey Demers, et al.. (2008). A Radiolabeled Oligonucleotide Ligation Assay Demonstrates the High Frequency of Nevirapine Resistance Mutations in HIV Type 1 Quasispecies of NVP-Treated and Untreated Mother–Infant Pairs from Uganda. AIDS Research and Human Retroviruses. 24(2). 235–250. 17 indexed citations

11.

Lalonde, Matthew S., Ryan M. Troyer, Aslam Syed, et al.. (2007). Sensitive Oligonucleotide Ligation Assay for Low-Level Detection of Nevirapine Resistance Mutations in Human Immunodeficiency Virus Type 1 Quasispecies. Journal of Clinical Microbiology. 45(8). 2604–2615. 27 indexed citations

12.

Baird, Heather, Yong Gao, Román Galetto, et al.. (2006). Influence of sequence identity and unique breakpoints on the frequency of intersubtype HIV-1 recombination. Retrovirology. 3(1). 91–91. 27 indexed citations

13.

Ahmed, Salahuddin, Ayesha Rahman, Absar-ul Hasnain, et al.. (2002). Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1β-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes. Free Radical Biology and Medicine. 33(8). 1097–1105. 223 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact